St. Michael's Hospital, Toronto Ontario.
VERO Biotech, Atlanta, Georgia.
Respir Care. 2022 Jan;67(1):115-128. doi: 10.4187/respcare.09294. Epub 2021 Nov 2.
Providing supplemental oxygen to hospitalized adults is a frequent practice and can be administered via a variety of devices. Oxygen therapy has evolved over the years, and clinicians should follow evidence-based practices to provide maximum benefit and avoid harm. This systematic review and subsequent clinical practice guidelines were developed to answer questions about oxygenation targets, monitoring, early initiation of high-flow oxygen (HFO), benefits of HFO compared to conventional oxygen therapy, and humidification of supplemental oxygen. Using a modification of the RAND/UCLA Appropriateness Method, 7 recommendations were developed to guide the delivery of supplemental oxygen to hospitalized adults: (1) aim for [Formula: see text] range of 94-98% for most hospitalized patients (88-92% for those with COPD), (2) the same [Formula: see text] range of 94-98% for critically ill patients, (3) promote early initiation of HFO, (4) consider HFO to avoid escalation to noninvasive ventilation, (5) consider HFO immediately postextubation to avoid re-intubation, (6) either HFO or conventional oxygen therapy may be used with patients who are immunocompromised, and (7) consider humidification for supplemental oxygen when flows > 4 L/min are used.
为住院成人提供补充氧气是一种常见的做法,可以通过各种设备进行。多年来,氧疗不断发展,临床医生应遵循循证实践,以提供最大的益处并避免伤害。本系统评价和随后的临床实践指南的制定是为了回答有关氧合目标、监测、早期开始高流量氧(HFO)、HFO 与常规氧疗相比的益处以及补充氧气加湿的问题。使用 RAND/UCLA 适宜性方法的修改版,制定了 7 项建议来指导为住院成人提供补充氧气:(1)大多数住院患者的[公式:见文本]范围为 94-98%(COPD 患者为 88-92%),(2)危重症患者的[公式:见文本]范围相同为 94-98%,(3)促进早期开始 HFO,(4)考虑 HFO 以避免升级为无创通气,(5)考虑 HFO 以避免拔管后再插管,(6)免疫功能低下的患者可以使用 HFO 或常规氧疗,(7)当流量>4L/min 时,考虑对补充氧气进行加湿。